Application of subanesthetic dose of esketamine combined with intravenous general anesthesia in bronchoscopy of children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053302

Enrollment

Unknown

Registered

2021-11-18

Start date

2021-11-22

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory diseases

Interventions

Esketamine group:Esketamine

Propofol group :Propofol

Eligibility

Sex/Gender

All

Age

3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 3-14 years; 2. ASA classification I-II.

Exclusion criteria

Exclusion criteria: 1. A history of psychological problems or mental illness; 2. Use of drugs that affect the central nervous system; 3. Children with impaired consciousness; 4. Children with elevated intracranial pressure; 5. Eyes Children with elevated internal pressure; 6. Children with congenital heart disease who shunt right to left.

Design outcomes

Primary

Measure	Time frame
Hemodynamic changes;Induced quality;Wake up quality;	—

Countries

China

Contacts

Public ContactZhong Yu

The First Affiliated Hospital of Guangxi Medical University

zzlugl@163.com+86 15177929679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026